Hunan Sundy Science And Technology
300515
Zhejiang Changsheng Sliding Bearings
300718
G.Tech Technology
301503
Juneway Electronic Technology
301458
Shanghai Cooltech Power
300153
CN Stock MarketDetailed Quotes
688177 Bio-Thera Solutions,
- 18.76
- -0.04-0.21%
Post-Market Auction Session Jan 20 15:00 CST
7.77BMarket Cap-20.57P/E (TTM)
19.18High18.71Low14.97KlotVolume18.78Open18.80Pre Close28.38MTurnover0.36%Turnover RatioLossP/E (Static)414.08MShares41.5052wk High9.17P/B7.77BFloat Cap17.7052wk Low22.56Limit Up414.08MShs Float78.00Historical High15.04Limit Down2.50%Amplitude17.09Historical Low--Dividend TTM18.96Avg Price5.84KlotAsk--Div YieldTTM100Lot Size8.12KlotBid
Bio-Thera Solutions, News
Express News | Bio-Thera Solutions Partners With Tabuk Pharmaceuticals to Commercialize Bat2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
Is Bio-Thera Solutions (SHSE:688177) A Risky Investment?
Bio-Thera Solutions Grants Costa Rican Pharma Firm Right to Market Autoimmune Drug
Express News | Bio-Thera Solutions Expands Partnership With Steincares in Latam With Addition of a Third Biosimilar to Partnership
Bio-Thera Solutions Receives $10 Million Payment Related to Licensing Deal
Bio-Thera Solutions, Ltd.'s (SHSE:688177) Last Week's 8.7% Decline Must Have Disappointed Private Companies Who Have a Significant Stake
Bio-Thera Solutions Enters Up to $110 Million Licensing Deal With Gedeon Richter
Express News | Hungary's Richter Says Bio-Thera Will Receive an Upfront Payyment of 8.5 Million USD -Statement
Express News | Hungary's Richter Says Bat2206 Is a Biosimilar Candidate to Stelara (Ustekinumab) -Statement
Express News | China's Bio-Thera and Hungary's Richter Execute Exclusive Commercialization Agreement for Bat2206 for EU Countries, UK, Switzerland and Other Countries
Bio-Thera Solutions, Ltd. (SHSE:688177) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Would Bio-Thera Solutions (SHSE:688177) Be Better Off With Less Debt?
Bio-Thera Solutions, Biogen Publish Phase 3 Clinical Trial Data for TOFIDENCE, An Approved Biosimilar Referencing Tocilizumab In Arthritis Research & Therapy
Bio-Thera Solutions' Cancer Drug Gets EU Marketing Approval
Express News | European Medicines Agency (EMA) Approves Bio-Thera Solutions' Bat1706 (Avzivi®, Bevacizumab), a Biosimilar Referencing Avastin®
What Bio-Thera Solutions, Ltd.'s (SHSE:688177) P/S Is Not Telling You
Bio-Thera Solutions Gets US FDA Application Acceptance for Digestive System Inflammation Injection
Express News | Bio-Thera Solutions Ltd - Study Expects to Enroll 676 Patients
Express News | Bio-Thera Solutions Initiates Integrated Phase I / Phase III Clinical Trial for Bat3306, a Proposed Biosimilar of Keytruda® (Pembrolizumab)
Express News | Bio-Thera Solutions Announces Regulatory Filing Acceptance for Bat2206, a Proposed Biosimilar to Stelara® in the US and EU
